Recent advances in noble metal complex based photodynamic therapy

Y Wu, S Li, Y Chen, W He, Z Guo - Chemical Science, 2022 - pubs.rsc.org
Photodynamic therapy (PDT) utilizes light-activated photosensitizers (PSs) to generate toxic
species for therapeutics. It has become an emerging solution for cancer treatment because …

Modulating glycolysis to improve cancer therapy

C Chelakkot, VS Chelakkot, Y Shin, K Song - International Journal of …, 2023 - mdpi.com
Cancer cells undergo metabolic reprogramming and switch to a 'glycolysis-
dominant'metabolic profile to promote their survival and meet their requirements for energy …

[HTML][HTML] Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer

M Liao, D Yao, L Wu, C Luo, Z Wang, J Zhang… - … Pharmaceutica Sinica B, 2024 - Elsevier
Cancer reprogramming is an important facilitator of cancer development and survival, with
tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation …

Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies

Y Zhang, Q Li, Z Huang, B Li, EC Nice, C Huang, L Wei… - Cancers, 2022 - mdpi.com
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …

Metabolic reprogramming by dual-targeting biomimetic nanoparticles for enhanced tumor chemo-immunotherapy

S Zang, K Huang, J Li, K Ren, T Li, X He, Y Tao, J He… - Acta Biomaterialia, 2022 - Elsevier
Abstract Cancer-associated fibroblasts (CAFs)-mediated metabolic support plays a vital role
in tumorigenesis. The metabolic network between cancer cells and CAFs may serve as …

[HTML][HTML] Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies

W Jia, Z Huang, L Zhou, YC Liou, F Di Virgilio… - Drug Resistance …, 2023 - Elsevier
Purinergic signalling, consisting of extracellular purines and purinergic receptors, modulates
cell proliferation, invasion and immunological reaction during cancer progression. Here, we …

Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy

Y Song, C Hu, Y Fu, H Gao - View, 2022 - Wiley Online Library
The blood–brain barrier (BBB) is a highly regulated and efficient barrier that controls the
mass transfer between blood and brain, severely limits brain penetration of systemically …

Molecular basis for inhibiting human glucose transporters by exofacial inhibitors

N Wang, S Zhang, Y Yuan, H Xu, E Defossa… - Nature …, 2022 - nature.com
Human glucose transporters (GLUTs) are responsible for cellular uptake of hexoses.
Elevated expression of GLUTs, particularly GLUT1 and GLUT3, is required to fuel the …

The significance of microenvironmental and circulating lactate in breast cancer

V Frisardi, S Canovi, S Vaccaro, R Frazzi - International Journal of …, 2023 - mdpi.com
Lactate represents the main product of pyruvate reduction catalyzed by the lactic
dehydrogenase family of enzymes. Cancer cells utilize great quantities of glucose, shifting …

Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy

H Zhang, Q Xue, Z Zhou, N He, S Li… - Frontiers in …, 2023 - frontiersin.org
Breast cancer (BC) is the most common malignancy in women worldwide, and the standard
treatment is chemotherapy or radiotherapy after surgery. In order to reduce the side effects of …